These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18220535)

  • 1. Radiosensitization of prostate cancer by soy isoflavones.
    Raffoul JJ; Sarkar FH; Hillman GG
    Curr Cancer Drug Targets; 2007 Dec; 7(8):759-65. PubMed ID: 18220535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
    Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
    Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
    Raffoul JJ; Banerjee S; Che M; Knoll ZE; Doerge DR; Abrams J; Kucuk O; Sarkar FH; Hillman GG
    Int J Cancer; 2007 Jun; 120(11):2491-8. PubMed ID: 17304503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soy Isoflavones Protect Normal Tissues While Enhancing Radiation Responses.
    Hillman GG
    Semin Radiat Oncol; 2019 Jan; 29(1):62-71. PubMed ID: 30573186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soy isoflavones sensitize cancer cells to radiotherapy.
    Hillman GG; Singh-Gupta V
    Free Radic Biol Med; 2011 Jul; 51(2):289-98. PubMed ID: 21605661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy.
    Sahin I; Bilir B; Ali S; Sahin K; Kucuk O
    Integr Cancer Ther; 2019; 18():1534735419835310. PubMed ID: 30897972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components.
    Zhou JR; Yu L; Zhong Y; Nassr RL; Franke AA; Gaston SM; Blackburn GL
    Prostate; 2002 Oct; 53(2):143-53. PubMed ID: 12242729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma.
    Hillman GG; Singh-Gupta V; Hoogstra DJ; Abernathy L; Rakowski J; Yunker CK; Rothstein SE; Sarkar FH; Gadgeel S; Konski AA; Lonardo F; Joiner MC
    Radiother Oncol; 2013 Oct; 109(1):117-25. PubMed ID: 24021346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soy isoflavones and prostate cancer: a review of molecular mechanisms.
    Mahmoud AM; Yang W; Bosland MC
    J Steroid Biochem Mol Biol; 2014 Mar; 140():116-32. PubMed ID: 24373791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer.
    Ahmad IU; Forman JD; Sarkar FH; Hillman GG; Heath E; Vaishampayan U; Cher ML; Andic F; Rossi PJ; Kucuk O
    Nutr Cancer; 2010; 62(7):996-1000. PubMed ID: 20924975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model.
    Wang Y; Raffoul JJ; Che M; Doerge DR; Joiner MC; Kucuk O; Sarkar FH; Hillman GG
    Radiat Res; 2006 Jul; 166(1 Pt 1):73-80. PubMed ID: 16808622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone.
    Dong X; Xu W; Sikes RA; Wu C
    Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice.
    Zhou JR; Gugger ET; Tanaka T; Guo Y; Blackburn GL; Clinton SK
    J Nutr; 1999 Sep; 129(9):1628-35. PubMed ID: 10460196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soy isoflavones augment radiation effect by inhibiting APE1/Ref-1 DNA repair activity in non-small cell lung cancer.
    Singh-Gupta V; Joiner MC; Runyan L; Yunker CK; Sarkar FH; Miller S; Gadgeel SM; Konski AA; Hillman GG
    J Thorac Oncol; 2011 Apr; 6(4):688-98. PubMed ID: 21325978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injury.
    Hillman GG; Singh-Gupta V; Runyan L; Yunker CK; Rakowski JT; Sarkar FH; Miller S; Gadgeel SM; Sethi S; Joiner MC; Konski AA
    Radiother Oncol; 2011 Nov; 101(2):329-36. PubMed ID: 22079530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging evidence on the role of soy in reducing prostate cancer risk.
    Messina MJ
    Nutr Rev; 2003 Apr; 61(4):117-31. PubMed ID: 12795445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitizing effect of cisplatin in prostate cancer cell lines.
    Geldof AA; Slotman BJ
    Cancer Lett; 1996 Mar; 101(2):233-9. PubMed ID: 8620475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lycopene and soy isoflavones in the treatment of prostate cancer.
    Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O
    Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization.
    Farhood B; Goradel NH; Mortezaee K; Khanlarkhani N; Salehi E; Nashtaei MS; Mirtavoos-Mahyari H; Motevaseli E; Shabeeb D; Musa AE; Najafi M
    Clin Transl Oncol; 2019 Mar; 21(3):268-279. PubMed ID: 30136132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptotic effects of cooked and in vitro digested soy on human prostate cancer cells.
    Dong X; Xu W; Sikes RA; Wu C
    Food Chem; 2012 Dec; 135(3):1643-52. PubMed ID: 22953905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.